HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Abstract
Inhibition of histone deacetylase (HDAC) activity induces growth arrest, differentiation, and, in certain cell types, apoptosis. FR901228, FK228, or depsipeptide, is an HDAC inhibitor effective in T-cell lymphomas. Adult T-cell leukemia (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1) and remains incurable. We examined whether FR901228 is effective for treatment of ATL by assessing its ability to induce apoptosis of HTLV-1-infected T-cell lines and primary leukemic cells from ATL patients. FR901228 induced apoptosis of Tax-expressing and -unexpressing HTLV-1-infected T-cell lines and selective apoptosis of primary ATL cells, especially those of patients with acute ATL. FR901228 also efficiently reduced the DNA binding of NF-kappaB and AP-1 in HTLV-1-infected T-cell lines and primary ATL cells and down-regulated the expression of Bcl-x(L) and cyclin D2, regulated by NF-kappaB. Although the viral protein Tax is an activator of NF-kappaB and AP-1, FR901228-induced apoptosis was not associated with reduced expression of Tax. In vivo use of FR901228 partly inhibited the growth of tumors of HTLV-1-infected T cells transplanted subcutaneously in SCID mice. Our results indicated that FR901228 could induce apoptosis of these cells and suppress the expression of NF-kappaB and AP-1 and suggest that FR901228 could be therapeutically effective in ATL.
AuthorsNaoki Mori, Takehiro Matsuda, Masayuki Tadano, Takao Kinjo, Yasuaki Yamada, Kunihiro Tsukasaki, Shuichi Ikeda, Yoshihiro Yamasaki, Yuetsu Tanaka, Takao Ohta, Teruo Iwamasa, Masao Tomonaga, Naoki Yamamoto
JournalJournal of virology (J Virol) Vol. 78 Issue 9 Pg. 4582-90 (May 2004) ISSN: 0022-538X [Print] United States
PMID15078940 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Retracted Publication)
Chemical References
  • Antibiotics, Antineoplastic
  • Depsipeptides
  • Histone Deacetylase Inhibitors
  • NF-kappa B
  • Peptides, Cyclic
  • Transcription Factor AP-1
  • romidepsin
Topics
  • Adult
  • Animals
  • Antibiotics, Antineoplastic (pharmacology, therapeutic use)
  • Apoptosis (drug effects)
  • Cell Line, Transformed
  • Depsipeptides
  • Disease Models, Animal
  • Down-Regulation
  • Histone Deacetylase Inhibitors
  • Human T-lymphotropic virus 1 (drug effects)
  • Humans
  • Leukemia, T-Cell (drug therapy)
  • Mice
  • Mice, SCID
  • NF-kappa B (drug effects, metabolism)
  • Peptides, Cyclic (pharmacology, therapeutic use)
  • T-Lymphocytes (virology)
  • Transcription Factor AP-1 (drug effects, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: